Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis

Acta Psychiatr Scand. 2012 Jan;125(1):45-53. doi: 10.1111/j.1600-0447.2011.01763.x. Epub 2011 Aug 29.

Abstract

Objective: Numerous studies have found a robust association between cannabis use and the onset of psychosis. Nevertheless, the relationship between cannabis use and the onset of early (or, in retrospect, prodromal) symptoms of psychosis remains unclear. The study focused on investigating the relationship between cannabis use and early and high-risk symptoms in subjects at clinical high risk for psychosis.

Method: Prospective multicenter, naturalistic field study with an 18-month follow-up period in 245 help-seeking individuals clinically at high risk. The Composite International Diagnostic Interview was used to assess their cannabis use. Age at onset of high risk or certain early symptoms was assessed retrospectively with the Interview for the Retrospective Assessment of the Onset of Schizophrenia.

Results: Younger age at onset of cannabis use or a cannabis use disorder was significantly related to younger age at onset of six symptoms (0.33 < r(s) < 0.83, 0.004 < P < 0.001). Onset of cannabis use preceded symptoms in most participants.

Conclusion: Our results provide support that cannabis use plays an important role in the development of psychosis in vulnerable individuals. Cannabis use in early adolescence should be discouraged.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Age of Onset
  • Behavioral Symptoms* / diagnosis
  • Behavioral Symptoms* / etiology
  • Female
  • Follow-Up Studies
  • Humans
  • Interview, Psychological / methods
  • Male
  • Marijuana Abuse* / complications
  • Marijuana Abuse* / diagnosis
  • Marijuana Abuse* / drug therapy
  • Marijuana Abuse* / epidemiology
  • Marijuana Abuse* / psychology
  • Patient Acceptance of Health Care / psychology
  • Prospective Studies
  • Psychiatric Status Rating Scales
  • Psychotic Disorders* / diagnosis
  • Psychotic Disorders* / drug therapy
  • Psychotic Disorders* / epidemiology
  • Psychotic Disorders* / etiology
  • Psychotic Disorders* / psychology
  • Psychotropic Drugs / therapeutic use*
  • Risk Factors
  • Self Report

Substances

  • Psychotropic Drugs